IFNG and B-cell chronic lymphocytic leukemia: To test this, we treated cells derived from seven CLL patients with 0.1% DMSO (vehicle control), 10 nM ONX-0914, 1 nM venetoclax, and their combination alone and in combination with 100 ng/mL IFNγ for 24 h.